Skip to main content
Journal of Health Monitoring logoLink to Journal of Health Monitoring
. 2017 Oct 9;2(3):77–83. doi: 10.17886/RKI-GBE-2017-070

Depressive symptoms among adults in Germany

Julia Bretschneider 1,, Ronny Kuhnert 1, Ulfert Hapke 1
PMCID: PMC10165911  PMID: 37168945

Abstract

Depressive symptoms imply a loss of quality of life, leading to increased morbidity and mortality as well as increased costs to the healthcare system. Information on the prevalence and distribution of depressive symptoms in the population is essential in light of planning prevention and care. GEDA 2014/2015-EHIS surveyed current depressive symptoms among adults in Germany through the Patient Health Questionnaire (PHQ-8). The surveyed prevalence of 10.1% indicates the widespread occurrence of depressive symptoms, regardless of an actual clinical diagnosis of depression. Prevalence for women (11.6%) is higher than for men (8.6%). Further differences exist concerning age and education as well as regional differences. The results are discussed in the light of the data available so far.

Keywords: PREVALENCE, DEPRESSIVE SYMPTOMS, DEPRESSION, HEALTH MONITORING, GERMANY

Introduction

Depression is one of the most common mental health disorders and is related to a high disease burden both for individuals suffering from the condition as also for society as a whole [1-3]. German social insurance carriers have recorded a significant increase in the role of depression in health services over the past few years, a process which has been accompanied by increasing public awareness [4-6].

The term depression covers a heterogeneous spectrum of depressive disorders which can be categorised for example with regard to the severity and course of depressive symptoms [7]. For a physician to diagnose depression requires, beyond simply confirming the presence of depressive symptoms, the fulfilment of specific diagnostic criteria, such as the presence of certain key symptoms. However, depressive symptoms such as despondency and loss of energy can also affect persons that do not fulfil the necessary clinical diagnostic criteria of depression and for example experience subthreshold depression, or experience such symptoms yet in the context of other mental and physical disorders. Among these are depressive symptoms related to emotionally stressful life events, substance abuse (alcohol, drugs, etc.) and chronic physical illness or as side effects of certain medications. Regardless of their diagnostic classification, depressive symptoms lead to a subjective deterioration in health and health-related quality of life [8, 9] and are associated with increased morbidity and mortality rates [10, 11]. Moreover, depressive symptoms increase the number of outpatient physician visits and sick leave days [12] and in particular in older age lead to increasing health service utilisation [13].

Epidemiological estimates on the prevalence and distribution of depression symptoms in the population are therefore highly relevant to public health and are an important basis for developing prevention and healthcare services. Health monitoring at the Robert Koch Institute initially collected prevalence data for the adult population in Germany in the German Health Interview and Examination Survey for Adults (DEGS1, 2008-2011) [14] and we now report the corresponding data from GEDA 2014/2015-EHIS.

GEDA 2014/2015-EHIS.

Data holder: Robert Koch Institute

Aims: To provide reliable information about the population’s health status, health-related behaviour and health care in Germany, with the possibility of a European comparison

Method: Questionnaires completed on paper or online

Population: People aged 18 years and above with permanent residency in Germany

Sampling: Registry office sample; randomly selected individuals from 301 communities in Germany were invited to participate

Participants: 24,016 people (13,144 women; 10,872 men)

Response rate: 26.9%

Study period: November 2014 - July 2015

Data protection: This study was undertaken in strict accordance with the data protection regulations set out in the German Federal Data Protection Act and was approved by the German Federal Commissioner for Data Protection and Freedom of Information. Participation in the study was voluntary. The participants were fully informed about the study’s aims and content, and about data protection. All participants provided written informed consent.

More information in German is available at

www.geda-studie.de

Indicator

GEDA 2014/2015-EHIS surveyed current depressive symptoms through a self-administered paper-based or online questionnaire. The survey applied a German version of the 8-item depression module of the Patient Health Questionnaire (PHQ-8) to evaluate symptoms of a major depressive disorder (but did not consider suicidal thoughts) in accordance with the DSM-IV manual (Diagnostic and Statistical Manual of Mental Disorders, 4th edition) regarding the presence and frequency of symptoms during the past two weeks [9, 15]: Depressed mood or irritable, decreased interest or pleasure, significant weight change or change in appetite, change in sleep, psychomotor agitation or retardation, fatigue or loss of energy, guilt/worthlessness, diminished ability to concentrate. Each of these eight items was rated on a scale between 0 (not at all), 1 (several days), 2 (more than half of the days) and 3 (nearly every day). Sum values between 10 and 24 indicate current depressive symptoms [9]. Prevalence in the following section is presented with 95% confidence intervals (95% CI) stratified by age, gender and educational level as well as federal state. Differences between these groups are interpreted as statistically significant if the respective confidence intervals do not overlap.

The analyses are based on data from 23,602 participants aged 18 years and older (12,900 women and 10,702 men) with valid PHQ-8 data. The calculations were carried out using a weighting factor that corrects for deviations within the sample from the German population (as of 31 December 2014) with regard to gender, age, district type and educational level. The International Standard Classification of Education (ISCED) was used to classify the responses provided on educational level [16]. A detailed description of the methodology used in the GEDA 2014/2015-EHIS study can be found in Lange et al. 2017 [17] as well as in the article German Health Update: New data for Germany and Europe, which was published in Issue 1/2017 of the Journal of Health Monitoring.

Results and discussion

The prevalence of current depressive symptoms among adults in Germany is 10.1% (Table 1). Prevalence among women (11.6%) is significantly higher than among men (8.6%). Gender differences are recorded across all age groups. Significant differences also exist with regard to age: Among women aged 18 to 29, prevalence is 16.4% and therefore higher than among older women. The lowest frequencies are recorded for women and men aged 65 and over (women 8.7%; men 5.4%).

Table 1.

Prevalence of depressive symptoms in the past 2 weeks (PHQ-8 score ≥10) according to gender, age and educational level (n=12,900 women; n=10,702 men)

Source: GEDA 2014/2015-EHIS

Women % (95% CI) Men % (95% CI)
Women total 11.6 (10.8-12.4) Men total 8.6 (7.9-9.4)
18-29 Years 16.4 (14.5-18.6) 18-29 Years 9.5 (7.7-11.7)
   Low education 22.4 (17.4-28.3)    Low education 13.9 (9.8-19.3)
   Medium education 15.7 (13.4-18.4)    Medium education 8.3 (6.4-10.6)
   High education 9.9 (7.5-13.0)    High education 7.0 (4.1-11.9)
30-44 Years 10.9 (9.5-12.4) 30-44 Years 9.4 (7.9-11.2)
   Low education 16.1 (11.5-22.1)    Low education 17.8 (12.2-25.2)
   Medium education 11.4 (9.6-13.4)    Medium education 10.1 (8.0-12.7)
   High education 6.4 (4.8-8.6)    High education 4.9 (3.5-6.8)
45-64 Years 11.9 (10.8-13.1) 45-64 Years 9.6 (8.5-10.7)
   Low education 17.5 (14.1-21.4)    Low education 15.3 (11.7-19.7)
   Medium education 11.8 (10.5-13.3)    Medium education 10.5 (9.0-12.3)
   High education 7.3 (6.0-8.9)    High education 5.9 (4.7-7.4)
≥ 65 Years 8.7 (7.4-10.1) ≥ 65 Years 5.4 (4.5-6.5)
   Low education 11.7 (9.4-14.4)    Low education 7.1 (4.8-10.5)
   Medium education 7.1 (5.4-9.3)    Medium education 5.7 (4.4-7.5)
   High education 3.6 (2.2-5.7)    High education 4.2 (3.0-5.9)
Total (women and men) 10.1 (9.6-10.7) Total (women and men) 10.1 (9.6-10.7)

CI=Confidence interval

Prevalence is lower among respondents with a high education level than with a medium or low one. Population prevalence of depressive symptoms thereby increases by the factor 2.5 (high education 5.9%; low education 14.8%, data not shown). Differences in prevalence with regard to levels of education are recorded across all age groups. Analyses that take into account age, gender and education indicate a prevalence of depressive symptoms of over one fifth (22.4%) of women with low education aged 18 to 29. Analogous analyses for men show the highest prevalence in those with low education aged 30 to 44 (17.8%). Prevalence is lowest in both genders for those aged over 65 with high education (women 3.6%; men 4.2%).

The prevalence of depressive symptoms varies between federal states (Figure 1). Women from Berlin and Brandenburg (14.6%) are nearly twice as likely to present depressive symptoms compared to women from Thuringia (7.4%). Significant differences in prevalence for men are found between Bavaria (5.7%) and Saarland (11.4%), as well as North-Rhine Westphalia (10.9%). Differences in prevalence between women and men are particularly high in Bavaria (11.2% vs. 5.7%) and Brandenburg (14.6% vs. 7.5%) and low in Saarland (11.0% vs. 11.4%) and Thuringia (7.4% vs. 7.9%).

Figure 1.

Figure 1

Prevalence of depressive symptoms during the past 2 weeks (PHQ-8 score ≥10) according to gender and federal state (n=12,900 women; n=10,702 men)

Source: GEDA 2014/2015-EHIS

Total prevalence (10.1%) is comparable to current findings from the US-American National Health and Nutrition Examination Survey (NHANES) and the Behavioral Risk Factor Surveillance System (BRFSS) [18, 19]. However, the new data is not consistent with data from previous surveys that were conducted in Germany. According to DEGS1 (2008-2011), the prevalence of depressive symptoms (8.1% overall, 6.1% for men) was significantly lower than the prevalence reported by the current survey [14]. An older population survey indicated an overall prevalence of 7.2%, which is even lower than the prevalence recorded by DEGS1 [20]. Whether these differences indicate a trend over time in the prevalence of depressive symptoms among adults and/or men in Germany is unclear and to clarify this question will require further comparative data, also because the PHQ version applied differed as did the surveyed age groups. In the US, however, an increase in depressive symptoms in the population has been documented since 2005 [18].

Previous surveys have already highlighted the importance of differences in prevalence between women and men [8, 14, 19]. The results highlight the importance of the age factor and are in line with the data available, according to which depressive symptoms among adults are clearly and particularly linked to younger age [12, 14, 19]. Equally, the links between depressive symptoms and education [8, 18] as well as socioeconomic status [12, 14, 21] are well known. No comparative data on the differences in prevalence between the German federal states is available. Regional differences could be related to a region’s age and social structure, but could also be related to differences in the spatial distribution of risk and protective factors. A comparison between cities and rural areas reveals different levels of prevalence, whereby the frequencies of depressive symptoms are higher in medium-sized and large cities than in small rural towns [12, 14].

The reported results can be classified in the context of available epidemiological findings on the prevalence of diagnoses of depression. GEDA 2014/2015-EHIS reports a 12-month prevalence of self-reported medical diagnoses of depression of 8.1% which is lower than the overall prevalence of depression symptoms. DEGS1 data (additional mental health module) too reveals a lower prevalence of diagnoses of depression that are recorded through standardised clinical interviews [12, 22, 23]; whereby methodological differences in the surveys need to be considered. When the definition of depressive symptoms according to PHQ is adjusted to include defining criteria for a diagnosis of depression, frequencies also drop [24]. A medical diagnosis moreover depends on patients turning to health services and is influenced by further factors such as healthcare services coverage [25].

To record depressive symptoms, the survey applied the internationally established PHQ instrument. Based on the results from GEDA 2014/2015-EHIS, we can make statements on the adult population in Germany. Identifying the particularly burdened segments of the population provides a basis to develop target groups to which to direct prevention and care. Moreover, the survey reveals relevant questions for future surveys on the prevalence of depressive symptoms, for example concerning trends over time and regional differences. The reported prevalence should be considered as conservative estimates because persons with acute or severe depression are less likely to participate in the survey [26].

Key statements

  • One in ten adults in Germany experiences current depressive symptoms.

  • Women aged 18 to 29 present a particularly high prevalence of depressive symptoms (16.4%).

  • A higher education translates into a lower prevalence of depressive symptoms.

  • The prevalence of depressive symptoms varies between federal states.

Funding Statement

The GEDA survey received funding from the Robert Koch Institute and the German Federal Ministry of Health.

Footnotes

Conflicts of interest

The authors declared no conflicts of interest.

Disclaimer

Note: External contributions do not necessarily reflect the opinions of the Robert Koch Institute

References

  • 1.Wittchen HU, Jacobi F, Rehm J, et al. (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(9):655-679 [DOI] [PubMed] [Google Scholar]
  • 2.World Health Organization (2016) Global Health Estimates 2015: Disease burden by Cause, Age, Sex, by Country and by Region, 2000-2015. www.who.int/entity/healthinfo/global_burden_disease/GHE2015_YLD_Global_2000_2015.xls?ua=1 (As at 02.06.2017)
  • 3.Mack S, Jacobi F, Beesdo-Baum K, et al. (2015) Functional disability and quality of life decrements in mental disorders: Results from the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). European Psychiatry 30:793-800 [DOI] [PubMed] [Google Scholar]
  • 4.Techniker Krankenkasse (eds) (2015) Depressionsatlas. Techniker Krankenkasse, Hamburg [Google Scholar]
  • 5.Kliner K, Rennert D, Richter M. (2015) Gesundheit in Regionen – Blickpunkt Psyche. BKK Dachverband, BKK Gesundheitsatlas 2015. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin [Google Scholar]
  • 6.Deutsche Rentenversicherung Bund (eds) (2014) Positionspapier der Deutschen Rentenversicherung zur Bedeutung psychischer Erkrankungen in der Rehabilitation und bei Erwerbsminderung. Deutsche Rentenversicherung Bund, Berlin [Google Scholar]
  • 7.Robert Koch-Institut (eds) (2010) Depressive Erkrankungen. Themenheft 51 Gesundheitsberichterstattung des Bundes. RKI, Berlin: http://edoc.rki.de/documents/rki_fv/re7w3qNkJP8NI/PDF/277vEuDUbrtzY.pdf (As at 02.06.2017) [Google Scholar]
  • 8.Kocalevent RD, Hinz A, Brähler E. (2013) Standardization of the depression screener Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry 35(5):551-555 [DOI] [PubMed] [Google Scholar]
  • 9.Kroenke K, Strine TW, Spitzer RL, et al. (2009) The PHQ-8 as a measure of current depression in the general population. J Affect Disord 114(1-3):163-173 [DOI] [PubMed] [Google Scholar]
  • 10.Jia H, Zack MM, Thompson WW, et al. (2015) Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide. Soc Psychiatry Psychiatr Epidemiol 50(6):939-949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Katon W, Ciechanowski P. (2002) Impact of major depression on chronic medical illness. J Psychosom Res 53(4):859-863 [DOI] [PubMed] [Google Scholar]
  • 12.Maske UE, Buttery AK, Beesdo-Baum K, et al. (2016) Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany. J Affect Disord 190:167-177 [DOI] [PubMed] [Google Scholar]
  • 13.Busch MA, Neuner B, Aichberger MC, et al. (2013) Depressive Symptomatik und Inanspruchnahme von Gesundheits- und Pflegeleistungen bei Personen im Alter ab 50 Jahren in Deutschland. Psychiat Prax 40(04):214-219 [DOI] [PubMed] [Google Scholar]
  • 14.Busch MA, Maske UE, Ryl L, et al. (2013) Prevalence of depressive symptoms and diagnosed depression among adults in Germany. Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 56(5-6):733-739 http://edoc.rki.de/oa/articles/reLPtVNhg9T2/PDF/22QgLkX1lQgU.pdf (As at 13.01.2017) [DOI] [PubMed] [Google Scholar]
  • 15.Löwe B, Spitzer RL, Zipfel S, et al. (2002) Gesundheitsfragebogen für Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Fragebögen, Schablonen. 2. Auflage. Pfizer, Karlsruhe [Google Scholar]
  • 16.Eurostat (2016) International standard classification of education (ISCED). http://ec.europa.eu/eurostat/statistics-explained/index.php/Glossary:International_standard_classification_of_education_%28ISCED%29 (As at 13.01.2017)
  • 17.Lange C, Finger JD, Allen J, et al. (in press) Implementation of the European Health Interview Survey (EHIS) in Germany. Further development of the German Health Update (GEDA) Archives of Public Health [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.McGee RE, Thompson NJ. (2015) Unemployment and depression among emerging adults in 12 states, Behavioral Risk Factor Surveillance System, 2010. Prev Chronic Dis 12:E38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wittayanukorn S, Qian J, Hansen RA. (2014) Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010. Gen Hosp Psychiatry 36(3):330-336 [DOI] [PubMed] [Google Scholar]
  • 20.Rief W, Nanke A, Klaiberg A, et al. (2004) Base rates for panic and depression according to the Brief Patient Health Questionnaire: a population-based study. J Affect Disord 82(2):271-276 [DOI] [PubMed] [Google Scholar]
  • 21.Lampert T, Kroll LE, von der Lippe E, et al. (2013) Socioeconomic status and healt. Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 56(5-6):814-821 http://edoc.rki.de/oa/articles/reJ1kvingLWZA/PDF/20dRwtjatiixk.pdf (As at 13.01.2017) [DOI] [PubMed] [Google Scholar]
  • 22.Jacobi F, Höfler M, Strehle J, et al. (2016) Erratum zu: Psychische Störungen in der Allgemeinbevölkerung. Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul „Psychische Gesundheit“ (DEGS1-MH). Der Nervenarzt 87:88-90 [DOI] [PubMed] [Google Scholar]
  • 23.Jacobi F, Höfler M, Strehle J, et al. (2014) Psychische Störungen in der Allgemeinbevölkerung: Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul Psychische Gesundheit (DEGS1-MH). Der Nervenarzt 85:77-87 [DOI] [PubMed] [Google Scholar]
  • 24.Maske UE, Busch MA, Jacobi F, et al. (2015) Current major depressive syndrome measured with the Patient Health Questionnaire-9 (PHQ-9) and the Composite International Diagnostic Interview (CIDI): results from a cross-sectional population-based study of adults in Germany. BMC Psychiatry 15(1):77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Melchior H, Schulz H, Härter M. (2014) Faktencheck Gesundheit – Regionale Unterschiede in der Diagnostik und Behandlung von Depressionen. Bertelsmann Stiftung, Gütersloh [Google Scholar]
  • 26.Schmidt CO, Watzke A-B, Schulz A, et al. (2013) Die Lebenszeitprävalenz psychischer Störungen in Vorpommern. Psychiat Prax 40(04):192-199 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Health Monitoring are provided here courtesy of Robert Koch Institute

RESOURCES